TOI - Oncology Institute Inc
Oncology Institute Inc Logo

TOI - Oncology Institute Inc

https://theoncologyinstitute.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
Bullish
The Oncology Institute Launches Lung Cancer Center of Excellence in Florida Led by International Oncology Expert Dr. Edgardo Santos - Oncology Institute ( NASDAQ:TOIIW ) , Oncology Institute ( NASDAQ:TOI )
Benzinga • 1 week, 5 days ago • score: 0.57
CERRITOS, Calif., Sept. 02, 2025 ( GLOBE NEWSWIRE ) -- The Oncology Institute of Hope and Innovation TOI, a leading value-based oncology practice, today announced the launch of its Lung Cancer Center of Excellence in Fort Lauderdale, Florida.
Bullish
The Oncology Institute and SilverSummit Healthplan Partner to Provide Oncology Care to Over 80,000 Medicaid Members in Nevada - Oncology Institute ( NASDAQ:TOIIW ) , Oncology Institute ( NASDAQ:TOI )
Benzinga • 2 months, 2 weeks ago • score: 0.53
CERRITOS, Calif., June 30, 2025 ( GLOBE NEWSWIRE ) -- The Oncology Institute, Inc. TOI ( "TOI" ) , one of the largest value-based oncology groups in the United States, announced today that effective July 1, it will be the exclusive oncology provider for over 80,000 Medicaid patients associated ...
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

None

52W High
$4.50
52W Low
$0.13

MA Status:
50D: Below 200D: Above
Beta (~1 neutral, <0.9 lower risk)
0.13
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-1.87
EV/Revenue (<3 favorable)
0.90
P/S (TTM) (<3 favorable)
0.73
P/B (<3 favorable)
0.76
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
8.88%
Institutions (25–75% balanced)
39.79%
Shares Outstanding
93,505,000
Float
77,563,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
424,376,000
Gross Profit (TTM)
63,752,000
EPS (TTM)
-0.67
Profit Margin (>10% good)
-0.16%
Operating Margin (TTM) (higher better)
-0.09%
ROE (TTM) (>15% strong)
-6.52%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.22
Momentum
Bearish momentum
Value
-0.1687
Previous
-0.1544
Trend
Falling
Signal Cross
No cross

As of
Sep. 12, 2025